Literature DB >> 4954866

Significance of bacterial variants in urine of patients with chronic bacteriuria.

L T Gutman, M Turck, R G Petersdorf, R J Wedgwood.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1965        PMID： 4954866      PMCID： PMC289696          DOI： 10.1172/JCI105300

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  15 in total

1.  Lysis of Mycoplasma, bacterial protoplasts, spheroplasts and L-forms by various agents.

Authors:  S RAZIN; M ARGAMAN
Journal:  J Gen Microbiol       Date:  1963-01

2.  Factors determining the outcome of chemotherapy in infections of the urinary tract.

Authors:  R I LINDEMEYER; M TURCK; R G PETERSDORF
Journal:  Ann Intern Med       Date:  1963-02       Impact factor: 25.391

3.  [The problem of pathogenicity of L-form bacteria (Review of the literature)].

Authors:  G Ia KAGAN
Journal:  Klin Med (Mosk)       Date:  1961-03

4.  [Effect of pathogenic L forms on cancer cell cultures].

Authors:  J LAVILLAUREIX
Journal:  C R Hebd Seances Acad Sci       Date:  1957-02-18

5.  In vitro sensitivity of some bacteria, their L forms and pleuropneumonia-like organisms to antibiotics.

Authors:  J R WARD; S MADOFF; L DIENES
Journal:  Proc Soc Exp Biol Med       Date:  1958-01

6.  The classification and nomenclature of organisms of the pleuropneumonia group.

Authors:  D G EDWARD; E A FREUNDT
Journal:  J Gen Microbiol       Date:  1956-02

7.  The isolation of protoplasts from Bacillus megaterium by controlled treatment with lysozyme.

Authors:  C WEIBULL
Journal:  J Bacteriol       Date:  1953-12       Impact factor: 3.490

8.  Bacterial variants in patients treated with chloramphenicol.

Authors:  A VOUREKA
Journal:  Lancet       Date:  1951-01-06       Impact factor: 79.321

9.  The transformation of typhoid bacilli into L forms under various conditions.

Authors:  L DIENES; H J WEINBERGER; S MADOFF
Journal:  J Bacteriol       Date:  1950-06       Impact factor: 3.490

10.  ACTION OF ERYTHROMYCIN ON "PROTOPLASTS" IN VIVO.

Authors:  L B GUZE; G M KALMANSON
Journal:  Science       Date:  1964-12-04       Impact factor: 47.728
View more
  33 in total

1.  Pharmacologic Basis for the Treatment of Pyelonephritis.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  1999-10       Impact factor: 3.725

2.  Remains of infection.

Authors:  Alan Barbour
Journal:  J Clin Invest       Date:  2012-06-25       Impact factor: 14.808

Review 3.  Bacterial persistence and expression of disease.

Authors:  G J Domingue; H B Woody
Journal:  Clin Microbiol Rev       Date:  1997-04       Impact factor: 26.132

4.  [Relapse and reinfection in chronic urinary tract infection in children. I. Isolation of microbial variants from urine (author's transl)].

Authors:  F Daschner; W Sietzen
Journal:  Med Microbiol Immunol       Date:  1974       Impact factor: 3.402

5.  Progressive kidney damage after non-obstructive urinary tract infection.

Authors:  A G Davies; M S McLachlan; A W Asscher
Journal:  Br Med J       Date:  1972-11-18

6.  [Serum resistance and "nephropathogenicity" of antigenetically defined E. coli strains. II. Behavior of different serum resistant bacilli in vitro].

Authors:  W Henkel
Journal:  Z Med Mikrobiol Immunol       Date:  1971

7.  The effect of preliminary sensitization and immunization on bacteriuria in rabbits with experimental pyelonephritis.

Authors:  K Záruba; O Vejbora; M Chobola
Journal:  Clin Exp Immunol       Date:  1971-09       Impact factor: 4.330

8.  Induction of L forms of Haemophilus influenzae in culture and their demonstration in human bronchial secretions.

Authors:  E M Lapinski; E D Flakas
Journal:  J Bacteriol       Date:  1967-04       Impact factor: 3.490

9.  Production of the Shwartzman reaction with microbial L forms.

Authors:  G M Kalmanson; M Y Kubota; L B Guze
Journal:  J Bacteriol       Date:  1968-09       Impact factor: 3.490

10.  Insights into the molecular basis of L-form formation and survival in Escherichia coli.

Authors:  William A Glover; Yanqin Yang; Ying Zhang
Journal:  PLoS One       Date:  2009-10-06       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.